Search by Drug Name or NDC

    NDC 51097-0001-02 Adasuve 10 mg/1 Details

    Adasuve 10 mg/1

    Adasuve is a RESPIRATORY (INHALATION) AEROSOL, POWDER in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alexza Pharmaceuticals, Inc.. The primary component is LOXAPINE.

    Product Information

    NDC 51097-0001
    Product ID 51097-001_0e8c19d4-bfd2-7c60-e063-6394a90a70e9
    Associated GPIs
    GCN Sequence Number 070405
    GCN Sequence Number Description loxapine AER POW BA 10 MG INHALATION
    HIC3 H7U
    HIC3 Description ANTIPSYCHOTICS, DOPAMINE AND SEROTONIN ANTAGONISTS
    GCN 33925
    HICL Sequence Number 039886
    HICL Sequence Number Description LOXAPINE
    Brand/Generic Brand
    Proprietary Name Adasuve
    Proprietary Name Suffix n/a
    Non-Proprietary Name loxapine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form AEROSOL, POWDER
    Route RESPIRATORY (INHALATION)
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name LOXAPINE
    Labeler Name Alexza Pharmaceuticals, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022549
    Listing Certified Through 2025-12-31

    Package

    NDC 51097-0001-02 (51097000102)

    NDC Package Code 51097-001-02
    Billing NDC 51097000102
    Package 5 INHALER in 1 CARTON (51097-001-02) / 1 AEROSOL, POWDER in 1 INHALER (51097-001-01)
    Marketing Start Date 2022-05-31
    NDC Exclude Flag N
    Pricing Information N/A